NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors

Detalles Bibliográficos
Autor principal: Meng, Xiang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255023/
https://www.ncbi.nlm.nih.gov/pubmed/37277194
http://dx.doi.org/10.1136/jitc-2023-007255
_version_ 1785056774311641088
author Meng, Xiang-Yu
author_facet Meng, Xiang-Yu
author_sort Meng, Xiang-Yu
collection PubMed
description
format Online
Article
Text
id pubmed-10255023
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102550232023-06-10 NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors Meng, Xiang-Yu J Immunother Cancer Letter BMJ Publishing Group 2023-06-05 /pmc/articles/PMC10255023/ /pubmed/37277194 http://dx.doi.org/10.1136/jitc-2023-007255 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Meng, Xiang-Yu
NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
title NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
title_full NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
title_fullStr NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
title_full_unstemmed NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
title_short NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
title_sort nlrc5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255023/
https://www.ncbi.nlm.nih.gov/pubmed/37277194
http://dx.doi.org/10.1136/jitc-2023-007255
work_keys_str_mv AT mengxiangyu nlrc5germlinevariantsaspotentialpharmacogenomicmarkersforimmunecheckpointinhibitors

Ejemplares similares